Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is COLESTIPOL HYDROCHLORIDE, with a corresponding US DMF Number 17651.
Remarkably, this DMF maintains an Active status since its submission on September 02, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 29, 2020, and payment made on September 22, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II